Align Technology, Inc. (ALGN)
NASDAQ: ALGN · Real-Time Price · USD
170.58
+3.77 (2.26%)
At close: Jan 8, 2026, 4:00 PM EST
170.52
-0.06 (-0.04%)
After-hours: Jan 8, 2026, 5:27 PM EST
Align Technology Market Cap
Align Technology has a market cap or net worth of $12.24 billion as of January 8, 2026. Its market cap has decreased by -22.92% in one year.
Market Cap
12.24B
Enterprise Value
11.39B
1-Year Change
-22.92%
Ranking
Category
Stock Price
$170.58
Market Cap Chart
Since January 30, 2001, Align Technology's market cap has increased from $769.80M to $12.24B, an increase of 1,489.91%. That is a compound annual growth rate of 11.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 12.03B | 7.37% |
| Dec 31, 2025 | 11.20B | -28.02% |
| Dec 31, 2024 | 15.57B | -25.83% |
| Dec 29, 2023 | 20.99B | 27.39% |
| Dec 30, 2022 | 16.47B | -68.21% |
| Dec 31, 2021 | 51.82B | 22.98% |
| Dec 31, 2020 | 42.14B | 91.60% |
| Dec 31, 2019 | 21.99B | 31.29% |
| Dec 31, 2018 | 16.75B | -5.97% |
| Dec 29, 2017 | 17.81B | 132.55% |
| Dec 30, 2016 | 7.66B | 46.35% |
| Dec 31, 2015 | 5.23B | 16.61% |
| Dec 31, 2014 | 4.49B | -2.19% |
| Dec 31, 2013 | 4.59B | 103.21% |
| Dec 31, 2012 | 2.26B | 21.17% |
| Dec 30, 2011 | 1.86B | 25.00% |
| Dec 31, 2010 | 1.49B | 12.37% |
| Dec 31, 2009 | 1.33B | 126.20% |
| Dec 31, 2008 | 586.60M | -48.68% |
| Dec 31, 2007 | 1.14B | 27.70% |
| Dec 29, 2006 | 895.10M | 122.94% |
| Dec 30, 2005 | 401.50M | -38.40% |
| Dec 31, 2004 | 651.80M | -32.58% |
| Dec 31, 2003 | 966.80M | 628.01% |
| Dec 31, 2002 | 132.80M | -38.40% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |